Returns
-0.01%
Loading chart...
Fundamentals
Large Cap
Financial - Banking
Market Cap (Cr)
17888.59
Earning Per Share
1.99
Dividend Yield
0.88%
P/E Ratio
285.68
P/B Ratio
7.72
Debt to Equity
0.15
Performance
min-value
max-value
Open
56,601.30
52-wk High
75,250.00
High
56,601.30
52-wk Low
75,250.00
Low
56,601.30
Band
75,250.00
Lower Circuit
56,601.30
Upper Circuit
75,250.00
Volume
56,601.30
VWAP
75,250.00
52 Week Performance
min-value
max-value

5.34% down side
up side5.34%

About the company
Jubilant Pharmova Limited was initially incorporated as 'Vam Organic Chemicals Limited' on June 21, 1978. The Company name was thereafter changed to 'Jubliant Organosys Limited' in November, 2001 and to 'Jubilant Life Sciences Limited' in October, 2009 and the Company attained its new name 'Jubilant Pharmova Limited' in February, 2021. Jubilant Pharmova Limited is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions. The Company is engaged in pharmaceuticals, contract research and development services and proprietary novel drugs. The pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of Active Pharmaceutical Ingredients (APIs), Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile Injectables and Non-Sterile Products through 6 US FDA approved manufacturing facilities in India, USA and Canada with a network of over 48 radiopharmacies in the USA.